Cartesian Therapeutics, Inc. · NASDAQ:RNAC
FMR LLC's stake in Cartesian Therapeutics, Inc. fell to 3.00% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 6, 2026
FMR LLC's stake in Cartesian Therapeutics, Inc. fell to 3.00%, 799,743 shares, as a passive investor on Mar 31, 2026. Filed May 6, 2026 (Schedule 13G/A).
- Stake
- 3.00%
- Shares
- 799,743
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 3.00% | 799,743 |
| Abigail P. Johnson | 3.00% | 799,743 |
Source
Related
- Cartesian Therapeutics, Inc.
- FMR LLC
- Cartesian Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Feb 5, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Jul 22, 2026
- Form 4 · Hoge Elizabeth · Apr 6, 2026
- Form 4 · Kalayoglu Murat · Apr 6, 2026
- Schedule 13G · Squarepoint Ops LLC · Mar 13, 2026